Home > News > Show Me A Sign
September 15th, 2005
Show Me A Sign
Joe Alper: Initial clinical trials with some of these apoptosis detectors have shown promise, and now investigators are bringing the power of nanotechnology to bear on this effort in order to create powerful systems that would ultimately be capable of both delivering an anti-tumor drug and monitoring, in real time, if it is triggering cell death. The development of a nanotechnology-enabled apoptosis detector is one of the strategic areas of emphasis of the NCI Alliance for Nanotechnology in Cancer.
Though this work is still in its early stages, its potential is a harbinger of things to come. "Having a real-time apoptosis detector would represent a significant advance in cancer therapy, one that would let us alter treatment to reflect how each patient responds to a given set of drugs soon after being given those drugs," remarked James Olson, M.D.
Air Force’s 30-year plan seeks 'strategic agility' August 1st, 2014
IBM Announces $3 Billion Research Initiative to Tackle Chip Grand Challenges for Cloud and Big Data Systems: Scientists and engineers to push limits of silicon technology to 7 nanometers and below and create post-silicon future July 10th, 2014
Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014
Local girl does good March 22nd, 2014
PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014
The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment: Targeted therapy for hepatocellular carcinoma using nanotechnology August 27th, 2014
Introducing the multi-tasking nanoparticle: Versatile particles offer a wide variety of diagnostic and therapeutic applications August 26th, 2014
Symphony of nanoplasmonic and optical resonators leads to magnificent laser-like light emission August 26th, 2014